287 related articles for article (PubMed ID: 34581026)
81. Exploration of epithelial-mesenchymal transition-related lncRNA signature and drug sensitivity in breast cancer.
Li C; Zheng L; Xu G; Yuan Q; Di Z; Yang Y; Dong X; Hou J; Wu G
Front Endocrinol (Lausanne); 2023; 14():1154741. PubMed ID: 37538794
[TBL] [Abstract][Full Text] [Related]
82. Identification of potential autophagy-associated lncRNA in prostate cancer.
Li J; Du H; Chen W; Qiu M; He P; Ma Z
Aging (Albany NY); 2021 May; 13(9):13153-13165. PubMed ID: 33971627
[TBL] [Abstract][Full Text] [Related]
83. Identification of a novel m6A-related lncRNA pair signature for predicting the prognosis of gastric cancer patients.
Wang JM; Li X; Yang P; Geng WB; Wang XY
BMC Gastroenterol; 2022 Feb; 22(1):76. PubMed ID: 35189810
[TBL] [Abstract][Full Text] [Related]
84. Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA.
Maimaiti A; Jiang L; Wang X; Shi X; Pei Y; Hao Y; Paerhati H; Zibibula Y; Abudujielili A; Kasimu M
Clin Neurol Neurosurg; 2021 Feb; 201():106464. PubMed ID: 33454543
[TBL] [Abstract][Full Text] [Related]
85. Integrated Analysis of RNA Binding Protein-Related lncRNA Prognostic Signature for Breast Cancer Patients.
Xu S; Xie J; Zhou Y; Liu H; Wang Y; Li Z
Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205391
[TBL] [Abstract][Full Text] [Related]
86. An eight-mRNA signature outperforms the lncRNA-based signature in predicting prognosis of patients with glioblastoma.
Gong Z; Hong F; Wang H; Zhang X; Chen J
BMC Med Genet; 2020 Mar; 21(1):56. PubMed ID: 32188434
[TBL] [Abstract][Full Text] [Related]
87. Comprehensive analysis of a novel lncRNA profile reveals potential prognostic biomarkers in clear cell renal cell carcinoma.
Liu T; Sui J; Zhang Y; Zhang XM; Wu WJ; Yang S; Xu SY; Hong WW; Peng H; Yin LH; Pu YP; Liang GY
Oncol Rep; 2018 Sep; 40(3):1503-1514. PubMed ID: 30015930
[TBL] [Abstract][Full Text] [Related]
88. Identification of Potential Prognostic Long Non-Coding RNA Biomarkers for Predicting Survival in Patients with Hepatocellular Carcinoma.
Liao X; Yang C; Huang R; Han C; Yu T; Huang K; Liu X; Yu L; Zhu G; Su H; Wang X; Qin W; Deng J; Zeng X; Ye X; Peng T
Cell Physiol Biochem; 2018; 48(5):1854-1869. PubMed ID: 30092592
[TBL] [Abstract][Full Text] [Related]
89. Metabolism-related long non-coding RNAs (lncRNAs) as potential biomarkers for predicting risk of recurrence in breast cancer patients.
Ma JY; Liu SH; Chen J; Liu Q
Bioengineered; 2021 Dec; 12(1):3726-3736. PubMed ID: 34254565
[TBL] [Abstract][Full Text] [Related]
90. Decoding the LncRNA transcriptome of esophageal cancer: identification of clinically relevant LncRNAs.
Khadirnaikar S; Narayanan SP; Shukla SK
Biomark Med; 2018 Oct; 12(10):1083-1093. PubMed ID: 30191740
[TBL] [Abstract][Full Text] [Related]
91. Long non-coding RNA p10247, high expressed in breast cancer (lncRNA-BCHE), is correlated with metastasis.
Yang YX; Wei L; Zhang YJ; Hayano T; Piñeiro Pereda MDP; Nakaoka H; Li Q; Barragán Mallofret I; Lu YZ; Tamagnone L; Inoue I; Li X; Luo JY; Zheng K; You H
Clin Exp Metastasis; 2018 Mar; 35(3):109-121. PubMed ID: 29948648
[TBL] [Abstract][Full Text] [Related]
92. A prognostic 3-long noncoding RNA signature for patients with gastric cancer.
Cheng P
J Cell Biochem; 2018 Nov; 119(11):9261-9269. PubMed ID: 30074647
[TBL] [Abstract][Full Text] [Related]
93. Long noncoding RNAs to predict postoperative recurrence in bladder cancer and to develop a new molecular classification system.
Li Z; Jiang L; Zhang Z; Deng M; Wei W; Tang H; Guo S; Ye Y; Yao K; Liu Z; Zhou F
Cancer Med; 2022 Jan; 11(2):539-552. PubMed ID: 34816620
[TBL] [Abstract][Full Text] [Related]
94. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
Han C; Zhang C; Wang H; Li K; Zhao L
BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
[TBL] [Abstract][Full Text] [Related]
95. Integrative analysis of prognostic long non-coding RNAs with copy number variation in bladder cancer.
Zhong W; Wang D; Yao B; Chen X; Wang Z; Qu H; Ma B; Ye L; Qiu J
J Zhejiang Univ Sci B; 2021 Aug; 22(8):664-681. PubMed ID: 34414701
[TBL] [Abstract][Full Text] [Related]
96. Four-lncRNA immune prognostic signature for triple-negative breast cancer Running title: Immune lncRNAs predict prognosis of TNBC.
Li YX; Wang SM; Li CQ
Math Biosci Eng; 2021 May; 18(4):3939-3956. PubMed ID: 34198419
[TBL] [Abstract][Full Text] [Related]
97. A potential prognostic long non-coding RNA signature to predict metastasis-free survival of breast cancer patients.
Sun J; Chen X; Wang Z; Guo M; Shi H; Wang X; Cheng L; Zhou M
Sci Rep; 2015 Nov; 5():16553. PubMed ID: 26549855
[TBL] [Abstract][Full Text] [Related]
98. Characterization of a 4 lncRNAs-based prognostic risk scoring system in adults with acute myeloid leukemia.
Zeng H; Wu H; Yan M; Tang L; Guo X; Zhao X
Leuk Res; 2020 Jan; 88():106261. PubMed ID: 31739140
[TBL] [Abstract][Full Text] [Related]
99. Identification and Validation of a Potential Prognostic 7-lncRNA Signature for Predicting Survival in Patients with Multiple Myeloma.
Zhong Y; Liu Z; Li D; Liao Q; Li J
Biomed Res Int; 2020; 2020():3813546. PubMed ID: 33204693
[TBL] [Abstract][Full Text] [Related]
100. Development and validation of a set of novel and robust 4-lncRNA-based nomogram predicting prostate cancer survival by bioinformatics analysis.
Zhang P; Tan X; Zhang D; Gong Q; Zhang X
PLoS One; 2021; 16(5):e0249951. PubMed ID: 33945533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
